Your search returned 3 results.

Results
	1.	Improvement of cardiovascular risk factors in heart transplant recipients after conversion from cyclosporine to tacrolimus: a role of the TGF-beta system. [electronic resource] by van Riemsdijk, I C Baan, C C Balk, A H M M Vantrimpont, P M A J Maat, L P W M Weimar, W Producer: 20030306 In: Transplantation proceedings vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Anti-CD25 therapy affects the death signals of activated T-cells after clinical heart transplantation. [electronic resource] by Baan, C C Balk, A H Mol, W M Van Riemsdijk, I C De Kuiper, P Van Gelder, T Vantrimpont, P M Maat, A P Weimar, W Publication details: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation Feb 2001 In: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Conversion from cyclosporin A to tacrolimus is safe and decreases blood pressure, cholesterol levels and TGF-beta 1 type I receptor expression. [electronic resource] by Baan, C C van Riemsdijk-van Overbeeke, I C Balk, A H Vantrimpont, P M Mol, W M Knoop, C J Niesters, H G Maat, L P Weimar, W Producer: 20011205 In: Clinical transplantation vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)